Attached files

file filename
10-Q - Q2 2016 10-Q - AS OF 6/30/16 - ARIAD PHARMACEUTICALS INCa2016q210-q.htm
EX-31.2 - EXHIBIT 31.2 - ARIAD PHARMACEUTICALS INCa2016q2exhibit312.htm
EX-31.1 - EXHIBIT 31.1 - ARIAD PHARMACEUTICALS INCa2016q2exhibit311.htm
EX-10.9 - EXHIBIT 10.9 - ARIAD PHARMACEUTICALS INCa2016q2exhibit109.htm
EX-10.8 - EXHIBIT 10.8 - ARIAD PHARMACEUTICALS INCa2016q2exhibit108.htm
EX-10.7 - EXHIBIT 10.7 - ARIAD PHARMACEUTICALS INCa2016q2exhibit107.htm
EX-10.6 - EXHIBIT 10.6 - ARIAD PHARMACEUTICALS INCa2016q2exhibit106.htm
EX-10.5 - EXHIBIT 10.5 - ARIAD PHARMACEUTICALS INCa2016q2exhibit105.htm
EX-10.4 - EXHIBIT 10.4 - ARIAD PHARMACEUTICALS INCa2016q2exhibit104.htm
EX-10.3 - EXHIBIT 10.3 - ARIAD PHARMACEUTICALS INCa2016q2exhibit103.htm
EX-10.2 - EXHIBIT 10.2 - ARIAD PHARMACEUTICALS INCv446216_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - ARIAD PHARMACEUTICALS INCv446216_ex10-1.htm


EXHIBIT 32.1
CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of ARIAD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the period ended June 30, 2016 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Dated: August 8, 2016
 
 
 
/s/ Paris Panayiotopoulos
 
 
 
 
Paris Panayiotopoulos
 
 
 
 
President and Chief Executive Officer
 
 
 
Dated: August 8, 2016
 
 
 
/s/ Manmeet S. Soni
 
 
 
 
Manmeet S. Soni
 
 
 
 
Executive Vice President,
 
 
 
 
Chief Financial Officer and Treasurer